SCHEDULE: T. Rowe Price Discloses 12% Stake in Anterix Inc.

T. Rowe Price Investment Management, Inc. has reported beneficial ownership of 12.0% of Anterix Inc.'s common stock as of June 30, 2026.

Summary

• T. Rowe Price Investment Management, Inc. has filed a Schedule 13G, indicating it beneficially owns 2,348,019 shares of Anterix Inc. common stock.
• This represents 12.0% of the class of securities.
• The filing date is July 8, 2026, with the event date requiring the filing being June 30, 2026.
• T. Rowe Price Investment Management, Inc. is identified as an investment adviser.
• The company explicitly denies beneficial ownership, stating the securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. While significant institutional ownership is generally positive, the explicit denial of beneficial ownership and lack of strategic commentary temper any strong positive sentiment.

Positives

• Significant institutional ownership by a reputable investment firm (T. Rowe Price) can be seen as a positive signal of confidence in the company's long-term prospects.
• The disclosure confirms a substantial investment, potentially leading to increased market visibility and stability.

Negatives

• The explicit denial of beneficial ownership by T. Rowe Price Investment Management, Inc. suggests their stake may be held in a fiduciary capacity rather than as a strategic investment aimed at control, which could limit their active influence.
• The filing does not provide details on the investment strategy or rationale behind acquiring this stake.

Risks

• Potential for future changes in T. Rowe Price's holdings, which could impact Anterix Inc.'s stock price.
• The explicit denial of beneficial ownership might indicate a passive investment, meaning T. Rowe Price may not actively engage in corporate governance or strategic direction, leaving such matters to other stakeholders.

Future Outlook

The filing itself does not contain forward-looking statements or guidance from Anterix Inc. It is a disclosure of ownership by T. Rowe Price Investment Management, Inc.

Management Comments

• T. Rowe Price Investment Management, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Investment Management is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied.
• By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11.

Industry Context

StockSavvy.ai notes that significant stake disclosures by major investment firms like T. Rowe Price are common in the telecommunications infrastructure sector, often signaling confidence or a strategic portfolio allocation. Anterix operates in the wireless spectrum management and infrastructure space, an industry undergoing consolidation and technological evolution.

Stakeholder Impact

• Shareholders: The disclosure may increase investor confidence due to the significant investment by a well-known asset manager, but the denial of beneficial ownership might limit expectations of active shareholder engagement.
• Management: The company may benefit from the stability and potential validation that comes with a large institutional holding, but may also face scrutiny if the investor's passive approach leads to underperformance.
• Creditors: A stable, significant institutional investor can be viewed positively, potentially indicating confidence in the company's financial stability.

Next Steps

• Monitor future filings from T. Rowe Price Investment Management, Inc. for any changes in their stake in Anterix Inc.
• Observe Anterix Inc.'s strategic communications for any indication of how this institutional ownership might influence corporate actions.

Key Dates

Keywords

Anterix Inc., T. Rowe Price Investment Management, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, SEC Filing, 12.0% Stake